文献速递脊柱关节炎

瑞典中轴型脊柱关节炎不良妊娠结局的时间趋势:一项队列研究

Temporal trends in adverse pregnancy outcomes in axial spondyloarthritis in Sweden: a cohort study.
PubMed 文献 · Lancet Rheumatol · 2023-01-30

这项基于瑞典登记数据的队列研究纳入2007年4月1日至2020年12月31日间1580例中轴型脊柱关节炎女性的分娩,按1:10匹配15792例一般人群对照,发现早产、子痫前期、择期剖宫产和严重婴儿感染风险升高,但上述风险在研究期间每年下降约0.5个百分点,同时妊娠期使用肿瘤坏死因子抑制剂增加。

要点

  • 中轴型脊柱关节炎女性早产风险比1.43(95%CI 1.13-1.80),子痫前期1.44(1.08-1.92)。
  • 择期剖宫产风险比1.59(1.37-1.84),严重婴儿感染风险比1.29(1.05-1.59)。
  • 研究期间早产、婴儿感染和剖宫产风险每年下降约0.5个百分点,妊娠期TNF抑制剂使用增加。

核心结论

  • 中轴型脊柱关节炎女性不良妊娠结局风险升高,但研究期间妊娠结局随时间改善,与生物类DMARD使用增加同时出现。
  • 作者认为若当前改善速度维持,按临床指南治疗的中轴型脊柱关节炎女性最终可能不再面临不良妊娠结局风险增加。

研究设计与样本

  • 基于登记的队列研究,纳入2007年4月1日至2020年12月31日瑞典1580例中轴型脊柱关节炎女性的分娩,按分娩年份、母亲年龄和产次1:10匹配15792例一般人群对照。
  • 主要数据源为瑞典医学出生登记(MBR),覆盖瑞典超过98%的分娩,并链接国家患者登记、处方药登记和人口学登记。
  • 主要结局为不良妊娠结局的相对风险,采用改良泊松回归分析;并用线性回归和loess图分析特定不良结局及DMARD和非甾体抗炎药使用随时间的变化。

主要发现

  • 与一般人群对照相比,中轴型脊柱关节炎女性早产风险比1.43(95%CI 1.13-1.80),子痫前期风险比1.44(95%CI 1.08-1.92)。
  • 择期剖宫产风险比1.59(95%CI 1.37-1.84),严重婴儿感染风险比1.29(95%CI 1.05-1.59)。
  • 研究期间早产、婴儿感染和剖宫产风险每年下降约0.5个百分点,同时妊娠期肿瘤坏死因子抑制剂使用增加。

关键数值与推荐

  • 早产风险比1.43(95%CI 1.13-1.80),子痫前期风险比1.44(95%CI 1.08-1.92),择期剖宫产风险比1.59(95%CI 1.37-1.84),严重婴儿感染风险比1.29(95%CI 1.05-1.59)。
  • 早产、婴儿感染和剖宫产风险在研究期间每年下降约0.5个百分点。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Evidence on the risks associated with pregnancy and childbirth in women with axial spondyloarthritis is scarce and conflicting, with more research needed to guide policy and clinical practice. We aimed to assess the risks of adverse pregnancy outcomes in a large cohort of women with axial spondyloarthritis, and to investigate how outcomes varied over time and in relation to anti-rheumatic treatment. METHODS: In this register-based cohort study, we included births in Sweden between April 1, 2007, and Dec 31, 2020, to women with axial spondyloarthritis and general population comparators, matched 1:10 on year of delivery, maternal age, and parity. Our main data source was the Medical Birth Register (MBR), which includes over 98% of births in Sweden and prospectively collects data on antenatal care, delivery, and foetal outcomes. The information in MBR was linked to other registers, including the National Patient Register, the Prescribed Drug Register, and registers with demographic data. Our main outcomes were the relative risks of adverse pregnancy outcomes, analysed using modified Poisson regression. We also studied how the frequency of certain adverse outcomes, as well as disease-modifying antirheumatic drug (DMARD) and non-steroidal anti-inflammatory drug treatments, changed over the study period by linear regression and loess plots. FINDINGS: Between April 1, 2007, and Dec 31, 2020, 1580 births in women with axial spondyloarthritis recorded in MBR fulfilled the inclusion criteria and were matched with 15 792 comparator births. Among the 1580 births in women with axial spondyloarthritis, we found increased risks of preterm birth (risk ratio 1·43, 95% CI 1·13-1·80), pre-eclampsia (1·44, 1·08-1·92), elective caesarean delivery (1·59, 1·37-1·84), and serious infant infection (1·29, 1·05-1·59) compared with births in general population comparators. The risks of preterm birth, infant infection, and caesarean delivery decreased by around 0·5 percentage points annually during the study period, while the use of tumour necrosis factor inhibitors during pregnancy increased. INTERPRETATION: In view of remaining concerns regarding safety of the use of biological DMARDs during pregnancy, we saw a reassuring trend in which pregnancy outcomes improved over time in the axial spondyloarthritis group, concurrent with increased use of biological DMARDs. If the current rate of improvement is maintained, women with axial spondyloarthritis treated in accordance with clinical guidelines might eventually not be at an increased risk of adverse pregnancy outcomes. FUNDING: Swedish Research Council and The Swedish Rheumatism Association.

来源:Lancet Rheumatol,查看原文。版权归原作者所有。

引用

  1. Morin M, Frisell T, Stephansson O, et al. Temporal trends in adverse pregnancy outcomes in axial spondyloarthritis in Sweden: a cohort study. Lancet Rheumatol. 2023. PMID: 38251608. doi:10.1016/S2665-9913(23)00001-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。